Cronos Group Inc. (CRON) fundamentals score
Cronos common shares are currently listed on the Toronto Stock Exchange (“TSX”) and on the NASDAQ Global Market (“Nasdaq”) under the trading symbol “CRON.”
Medicinal Chemicals & Botanical Products · Healthcare · Listed on NASDAQ
Overall: 8.1 out of 10, Strong long-term fundamentals
- Growth: 9.7/10
- Profitability: 5.3/10
- Financial health: 9.5/10
- Earnings quality: 7.5/10
- Valuation: 9.1/10
Scores are calculated from Cronos Group Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10